NPI: 1821043977 · INDIANAPOLIS, IN 46203 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/24/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,302 | $296K |
| 2019 | 24,529 | $345K |
| 2020 | 16,073 | $309K |
| 2021 | 14,263 | $321K |
| 2022 | 17,488 | $376K |
| 2023 | 7,499 | $287K |
| 2024 | 3,008 | $172K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 41,193 | 2,744 | $1.78M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 33,799 | 1,457 | $210K |
| J1756 | Injection, iron sucrose, 1 mg | 9,002 | 1,625 | $52K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 812 | 314 | $50K |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,511 | 1,252 | $16K |
| 83970 | 438 | 316 | $32.95 | |
| 82728 | 324 | 249 | $8.66 | |
| 83550 | 355 | 268 | $5.56 | |
| A4657 | Syringe, with or without needle, each | 1,598 | 936 | $4.84 |
| 83540 | 356 | 269 | $4.12 | |
| 85041 | 848 | 593 | $4.06 | |
| 85048 | 846 | 593 | $3.39 | |
| G0008 | Administration of influenza virus vaccine | 15 | 14 | $0.00 |
| 82607 | 25 | 14 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 17 | 15 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 23 | 13 | $0.00 |